Oregon Drug Take Back Program Stakeholders Process

1
Oregon Drug Take Back ProgramStakeholders
Process
2
Co-Chairs

• Tony Burtt
• Oregon Board of Pharmacy
• Tom Penpraze
• City of Corvallis Public Works Department
• Facilitator
• Janet Gillaspie Oregon Association of Clean
  Water Agencies

3
Summary

• Oregon Drug Take Back Stakeholder Group
• Introductions
• Process
• Recommendations

4
Stakeholders Group

• Jim Hill
• City of Medford/ACWA
• Brett Hulstrom
• City of Portland BES
• Lis Houchen
• NACDS
• Abby Boudouris
• Oregon DEQ
• Teresa Huntsinger
• OR Env. Council

• Ann Jackson
• OR Hospice Association
• Tanya Drayden
• OR Poison Center
• Dave Leland
• OR Public Health Division
• Kristan Mitchell
• OR Refuse Recycling Assoc.

5
Stakeholder Group

• Gerry Migaki
• OR Society of Health-System Pharmacists
• Jim Thompson
• OR State Pharmacy Assoc.
• Mike Dingeman Becki David
• OR State Police

• Leslie Wood
• PhRMA
• Brenda Bateman
• Lacey Gores
• OR Water Utilities Council
• Bill Etter
• Drug Enf. Administration

6
Developing an Oregon Drug Take Back Program

• Stakeholder group process
• Graduate student for research
• Funded by
• ACWA
• Oregon Water Utilities Council
• Oregon DEQ
• Others

7
Stakeholder Group

• Oregon Board of Pharmacy
• Oregon DEQ
• City of Corvallis
• Portland Bureau of Env. Services
• ACWA
• Natl Assoc. of Chain Drug Stores
• Oregon Env. Council
• Oregon Hospice Assoc.
• Oregon Poison Center
• Oregon Public Health Division Drinking Water
  Program

• Oregon Refuse Recycling Association
• Oregon Society of Health-System Pharmacists
• Oregon State Pharmacy Assoc.
• Oregon State Police
• Pharmaceutical Research Manufacturers of
  America (PhRMA)
• OR Water Utilities Council
• Tualatin Valley Water Dist.
• US Drug Enforcement Admin.

8
Stakeholder Process

• Examined regulatory framework
• State and Federal
• Examined other programs
• Clark County, Maine, San Francisco, Washington,
  BC
• Considered funding and organizational options
• Responsible agencies, funding options
• Considered landfilling of unwanted drugs
• Preferred option White House Council, PhRMA
• OSU review
• Developed recommendations

9
Developing an OregonDrug Take Back Program

• Stakeholder Group
• Met from October 2006 to July 2007
• Detailed research report
• 111 page report
• Full report at www.oracwa.org
• Recommendations for Oregon program
• Pharmaceutical Research Manufacturers of
  America (PhRMA) does not support

10
Why Drug Take Back?

• Reduce avoidable poisonings
• Children adults
• Prevent prescription drug abuse addiction
• Mostly teens
• Protect water quality

11
Why?

• Reduce avoidable poisonings
• For Oregon children, poisoning is the 2nd
  leading cause of injury hospitalization
• Oregon s hospitalization rate for unintentional
  poisoning for children under 18 increased 60
  between 2000 and 2006
• Much due to prescription medications

12
Why?

• Prevent prescription drug abuse addiction
• Misuse of prescription drugs only second to
  marijuana as nations most prevalent illegal drug
  problem
• Average number of people using pain relievers
  non-medically for the first time exceeds new
  marijuana users
• Young people get drugs from family and friends

13
Why?

• USGS study found microcontaminants in 80 of the
  streams sampled
• Included Oregon
• Cant distinguish between flushed and excreted
• Detected in landfill leachate
• Landfills often connect to wastewater treatment
  plants
• Industry estimates that 3 - 10 unused
• 3 of Oregon prescriptions 1 million
  prescriptions

14
Regulatory Challenges for Controlled Drugs

• DEA Regulations
• After being dispensed, controlled drugs can only
  be possessed by
• Patient
• Law enforcement
• Cannot be returned to a pharmacy

15
Regulatory Challenges for Controlled Drugs

• Controlled drugs include
• OxyContin
• Morphine
• Ritalin
• More

16
British Columbia

• Medicines Return program
• Virtually all BC pharmacies participate
• In 2006, collected 44,000 pounds
• 257,000 CN
• No reported incidents of abuse in the 10 years of
  the program operation
• Most drug companies that serve BC, serve Oregon

17
Building An Oregon Program

• Estimating 60,000 pounds of unwanted drugs
  annually in Oregon
• Based on existing program in British Columbia

18
Oregon Recommendations

• Product stewardship model
• Drug manufacturers - including generic and over
  the counter
• Organized and paid for by industry
• 2009 Oregon legislative action
• Product stewardship program for safe return of
  unwanted and unused drugs